[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@_joebaffoe Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::896026242125766656.png) @_joebaffoe Joseph M. Baffoe

Joseph M. Baffoe posts on X about $chrs, $230m, targets, $rgti the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::896026242125766656/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::896026242125766656/c:line/m:interactions.svg)

- X Week XXX -XX%
- X Month XXXXX -XX%
- X Months XXXXXX -XX%
- X Year XXXXXXX +241%

### Mentions: X [#](/creator/twitter::896026242125766656/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::896026242125766656/c:line/m:posts_active.svg)

- X Months XX -XX%
- X Year XXX +198%

### Followers: XXXXX [#](/creator/twitter::896026242125766656/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::896026242125766656/c:line/m:followers.svg)

- X Week XXXXX +2.60%
- X Month XXXXX +2.30%
- X Months XXXXX +14%
- X Year XXXXX +56%

### CreatorRank: undefined [#](/creator/twitter::896026242125766656/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::896026242125766656/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::896026242125766656/influence)
---

**Social category influence**
[finance](/list/finance)  XXXXX% [exchanges](/list/exchanges)  XXXX%

**Social topic influence**
[$chrs](/topic/$chrs) #3, [$230m](/topic/$230m) 6.67%, [targets](/topic/targets) 6.67%, [$rgti](/topic/$rgti) 6.67%, [money](/topic/money) 6.67%, [stocks](/topic/stocks) 6.67%, [$54m](/topic/$54m) 6.67%, [nasdaq](/topic/nasdaq) XXXX%

**Top accounts mentioned or mentioned by**
[@9ematrading](/creator/undefined) [@stevewagsinvest](/creator/undefined) [@rcangiolosi](/creator/undefined) [@bobbybetterdeal](/creator/undefined) [@deputydewey3](/creator/undefined) [@bbackal](/creator/undefined) [@vanjohn10](/creator/undefined) [@billmiller32](/creator/undefined) [@corleonedon77](/creator/undefined) [@fiercebiotech](/creator/undefined) [@seekingalpha](/creator/undefined) [@biostocks](/creator/undefined) [@alancastle15](/creator/undefined) [@madmoneyoncnbc](/creator/undefined) [@cnbcfastmoney](/creator/undefined) [@johncaia](/creator/undefined) [@biotechsd](/creator/undefined) [@biotechch](/creator/undefined) [@tpusa](/creator/undefined) [@qniatof](/creator/undefined)

**Top assets mentioned**
[Rigetti Computing, Inc. Common Stock (RGTI)](/topic/$rgti)
### Top Social Posts [#](/creator/twitter::896026242125766656/posts)
---
Top posts by engagements in the last XX hours

"$CHRS Just remember the day they announced the divestiture of #Udenyca the stock gapped to $XXXX. Immediately the shorts started attacking knocking it down hence the XX% short one of the highest I've ever seen. This stock with an approved drug about to get their label expanded for multiple indications with $230M in cash plus great data readouts in the next 6-12 months working on multiple partnership opportunities in X combo trials with other Pharma's I will sell half my position at $X and let the rest ride for 2-3 years. @9ematrading @SteveWagsInvest @john_caia @RCangiolosi @bobbybetterdeal"  
[X Link](https://x.com/_joebaffoe/status/1963954348393996612) [@_joebaffoe](/creator/x/_joebaffoe) 2025-09-05T13:16Z 1354 followers, XXX engagements


"$CHRS GROK is my buddy The immediate next resistance level is approximately $XXXX which represents a confluence of accumulated volume from prior highs the upper boundary of a recent ascending channel and a short-term moving average cluster around $1.55$1.65. If $XXXX is breached and holds as new support the stock could accelerate toward higher targets of $4$5. @SteveWagsInvest @vanjohn10 @BillMiller32 @AlanCastle15 @RCangiolosi @bobbybetterdeal @deputydewey3 @CorleoneDon77 @BBackal @9ematrading @BioStocks @MadMoneyOnCNBC @CNBCFastMoney @SeekingAlpha @FierceBiotech"  
[X Link](https://x.com/_joebaffoe/status/1968331771973378176) [@_joebaffoe](/creator/x/_joebaffoe) 2025-09-17T15:10Z 1357 followers, XXX engagements


"$CHRS talk about printing money $RGTI has gone from XX cents per share October of XX to $XX today. 200000 shares cost you $140000 now worth $5.4M 50M shares traded today. Watching Coherus' Chief Science officer Theresa LaVallee describe next data readouts for CHS-114 CCR8+Tregs enabling selective depletion of tumor immune suppression without systemic autoimmunity" is the next GOLD RUSH in cancer treatment. Positive data readout first half of next year and this stock will explode @SteveWagsInvest @vanjohn10 @9ematrading @RCangiolosi @BillMiller32 @AlanCastle15 @bobbybetterdeal @deputydewey3"  
[X Link](https://x.com/_joebaffoe/status/1969057296333623488) [@_joebaffoe](/creator/x/_joebaffoe) 2025-09-19T15:13Z 1353 followers, XXX engagements


"$CHRS close above $XXXX today test $X next week. X Data readouts by first half of 2026. @9ematrading @SteveWagsInvest @vanjohn10 @RCangiolosi @BBackal @BillMiller32 @CorleoneDon77 @deputydewey3 @bobbybetterdeal"  
[X Link](https://x.com/_joebaffoe/status/1974111801890779512) [@_joebaffoe](/creator/x/_joebaffoe) 2025-10-03T13:58Z 1355 followers, XXX engagements


"$CHRS 200000 shares on the open"  
[X Link](https://x.com/_joebaffoe/status/1976279942376927647) [@_joebaffoe](/creator/x/_joebaffoe) 2025-10-09T13:33Z 1355 followers, XXX engagements


"$CHRS @SteveWagsInvest @vanjohn10 @RCangiolosi @BBackal @BillMiller32 @9ematrading @deputydewey3 @bobbybetterdeal @CorleoneDon77 @FierceBiotech"  
[X Link](https://x.com/_joebaffoe/status/1976637945663926676) [@_joebaffoe](/creator/x/_joebaffoe) 2025-10-10T13:16Z 1355 followers, XXX engagements


"No Coherus BioSciences Inc. (NASDAQ: CHRS) does not have five clinical data readouts scheduled in the next nine months (October XX 2025 to July XX 2026). Coherus a commercial-stage oncology company has several ongoing Phase 1b and Phase X trials for its pipeline candidates including CHS-114 (an anti-CCR8 antibody) and casdozokitug (an IL-27 antagonist). However based on their latest financial reports and analyst coverage all major first data readouts are targeted for the first half of 2026 (JanuaryJune 2026) which falls within the nine-month window. These include: Phase X randomized trial of"  
[X Link](https://x.com/_joebaffoe/status/1977016692191698955) [@_joebaffoe](/creator/x/_joebaffoe) 2025-10-11T14:21Z 1355 followers, XXX engagements


"@qniatof @9ematrading @SteveWagsInvest @vanjohn10 @RCangiolosi @BBackal @BillMiller32 @CorleoneDon77 @deputydewey3 @bobbybetterdeal $CHRS"  
[X Link](https://x.com/_joebaffoe/status/1977025567053803558) [@_joebaffoe](/creator/x/_joebaffoe) 2025-10-11T14:56Z 1355 followers, XXX engagements


"$CHRS feels like it's going to break through the $XXXX resistance today question is does it close above $X @9ematrading @SteveWagsInvest @vanjohn10 @bobbybetterdeal @miller @RCangiolosi @BBackal @deputydewey3 @FierceBiotech @SeekingAlpha @BioStocks @Stocktwits"  
[X Link](https://x.com/_joebaffoe/status/1980641601325260908) [@_joebaffoe](/creator/x/_joebaffoe) 2025-10-21T14:25Z 1364 followers, XXX engagements